Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets
Benhalima K, Beunen K, Siegelaar S, Painter R, Murphy H Et AlLancet Diabetes Endocrinol. 2023 Jun 5;S2213-8587(23)00116-X.
https://doi.org/10.1016/S2213-8587(23)00116-X

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update
Samson S, Vellanki P, Blonde L, Christofides E, Umpierrez G et al
On line 5 mayo 2023, Endocrine Practice
https://doi.org/10.1016/j.eprac.2023.02.001

Impacts of COVID-19 on Glycemia and Risk of Diabetic Ketoacidosis
Sharma A, Misra-Heberth A, Mariam A, Milinovich A, Onuzuruike, A et al
Diabetes 2023;72(5):627–637
https://doi.org/10.2337/db22-0264

Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes
Heller S, Battelino, Bailey T, Pieber T, Pieber T et al
doi.org/10.1111/dom.14987

Management of adults with diabetes on dialysis: Summary of recommendations of the Joint British Diabetes Societies guidelines 2022
Frankel A, Whaba M,  Ashworth V, Bedi R, Berrington et al
https://doi.org/10.1111/dme.15027

Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study)
Moser O,  Muller F, Aberer F, Aziz F; koizar H et al
Diabetes Technol Ther. 2023 Mar;25(3):161-168.
https://doi.org/10.1089/dia.2022.0422

Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial.
Feig D, Sanchez J, Murphy K, Astalos E, Zinman B, Sinmons D  et al.
Lancet Diabetes Endocrinol. 2023 Mar;11(3):191-202. 
www.doi.org/10.1016/S2213-8587(23)00004-9

Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled In Range trial
Battelino T, Danne T, Edelman S, Choudhary P, Renard E et al
Diabetes, obesity and metabolism
https://doi.org/10.1111/dom.14898

Standards of Care in Diabetes-2023
Diabetes Care December 2022, Vol.46, S1-S284
https://doi.org/10.2337/dc23-Sint

Fasting and meal-stimulated serum C-peptide in long-standing type 1 diabetes mellitus
Vollenbrock C, Mul D, Dekker P, Birnie E, de Vries-Velraeds M, Boesten et al
Diabetic Medicine 
https://www.doi.org/10.1111/dme.15012